About: http://linked.opendata.cz/resource/sukl/spc/section/SPC142728_doc-4-3     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : salt:Section, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
salt:hasSectionTitle
  • 4.3 Kontraindikace (cs)
salt:hasOrderNumber
  • 004.003
salt:hasText
  • Hypersenzitivita na escitalopram nebo na kteroukoliv pomocnou látku. Současná léčba neselektivními ireverzibilními inhibitory monoaminooxidázy (MAO-inhibitory) je kontraindikovaná vzhledem k riziku serotoninového syndromu doprovázeného agitovaností, třesem, hypertermií atd.(viz bod 4.5). Kombinovaná léčba escitalopramem a reverzibilními MAO-A inhibitory (např. moklobemid) nebo neselektivním MAO-inhibitorem linezolidem je kontraindikovaná vzhledem k riziku vzniku serotoninového syndromu (viz bod 4.5). (cs)
salt:hasParagraph
is salt:hasSection of
is salt:hasSubSection of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 89 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software